ClinicalTrials.gov
ClinicalTrials.gov Menu

Comparing a Closing System Without a Needle With Positive Pressure to a Heparin Lock With Positive Pressure

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00386451
Recruitment Status : Completed
First Posted : October 11, 2006
Last Update Posted : April 27, 2009
Sponsor:
Information provided by:
University Hospital, Ghent

Brief Summary:

A prospective randomized study to compare 2 groups:

  • heparine lock with positive pressure
  • lock without a needle with positive pressure

Condition or disease Intervention/treatment Phase
Neoplasms Device: Catheter locking systems Not Applicable

Study Type : Interventional  (Clinical Trial)
Estimated Enrollment : 60 participants
Allocation: Randomized
Intervention Model: Single Group Assignment
Masking: None (Open Label)
Primary Purpose: Treatment
Official Title: Prospective Study Which Compares the Use of a Closing System Without a Needle and With Positive Pressure to a Heparin Lock With Positive Pressure for Patients With a Catheter for Chemotherapy
Study Start Date : November 2006
Actual Primary Completion Date : July 2007
Actual Study Completion Date : July 2007

Resource links provided by the National Library of Medicine

MedlinePlus related topics: Blood Thinners
Drug Information available for: Heparin
U.S. FDA Resources




Primary Outcome Measures :
  1. Clinical evaluation


Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   18 Years and older   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Oncological patients who require intravenous chemotherapy

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00386451


Locations
Belgium
University Hospital Ghent
Ghent, Belgium, 9000
Sponsors and Collaborators
University Hospital, Ghent
Investigators
Principal Investigator: Caren Randon, MD University Hospital, Ghent

Additional Information:
Responsible Party: Caren Randon, University Hospital Ghent
ClinicalTrials.gov Identifier: NCT00386451     History of Changes
Other Study ID Numbers: 2006/331
First Posted: October 11, 2006    Key Record Dates
Last Update Posted: April 27, 2009
Last Verified: April 2009

Keywords provided by University Hospital, Ghent:
Intravenous chemotherapy

Additional relevant MeSH terms:
Heparin
Anticoagulants
Fibrinolytic Agents
Fibrin Modulating Agents
Molecular Mechanisms of Pharmacological Action